3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Follicular
20
Lymphoma
19
Lymphoma, Mantle-Cell
17
Leukemia, Lymphocytic, Chronic, B-Cell
15
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma, B-Cell, Marginal Zone
10
Lymphoma, B-Cell
10
Lymphoma, Non-Hodgkin
9
Recurrence
6
Hodgkin Disease
6
Waldenstrom Macroglobulinemia
5
Neoplasms
3
Multiple Myeloma
3
Leukemia
3
Burkitt Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphatic Diseases
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Sezary Syndrome
1
Proteostasis Deficiencies
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Neurotoxicity Syndromes
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Interventions
Fulvestrant
125
Trastuzumab
115
Paclitaxel
113
Letrozole
108
pembrolizumab
79
pertuzumab
75
palbociclib
75
Anastrozole
72
Capecitabine
71
Cyclophosphamide
69
Carboplatin
67
abemaciclib
64
exemestane
63
Tamoxifen
63
ribociclib
61
trastuzumab deruxtecan
58
Surveys and Questionnaires
51
Specimen Handling
50
Radiotherapy
48
Magnetic Resonance Spectroscopy
48
Docetaxel
48
Blood Specimen Collection
40
olaparib
39
Standard of Care
37
Biopsy
34
sacituzumab govitecan
31
130-nm albumin-bound paclitaxel
31
Exercise
29
Doxorubicin
29
eribulin
27
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Bendamustine Hydrochloride
×
1 year
×
Clear all
No trials found.